Comprehensive Financial Consultants Institutional’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
AIM
FWIA
DLA
Comprehensive Financial Consultants Institutional's BMY Position: Q2 2026 in Review
Comprehensive Financial Consultants Institutional increased its Bristol-Myers Squibb (BMY) stake by 1.4% in Q2 2026, buying an estimated $19.3K and bringing the position to 23,558 shares worth $1.36M. The position accounts for 0.36% of the portfolio, ranked #90.
Comprehensive Financial Consultants Institutional first reported a position in BMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.41M in Q1 2026. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Comprehensive Financial Consultants Institutional held 23,558 shares of Bristol-Myers Squibb worth $1.36M as of Q2 2026.
- Comprehensive Financial Consultants Institutional bought 336 Bristol-Myers Squibb shares in Q2 2026, an estimated $19.3K.
- Bristol-Myers Squibb made up 0.36% of Comprehensive Financial Consultants Institutional's portfolio in Q2 2026, its #90 holding.
- Comprehensive Financial Consultants Institutional first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 19 quarters since.
- Comprehensive Financial Consultants Institutional's Bristol-Myers Squibb position peaked at $1.41M in Q1 2026.
- 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Comprehensive Financial Consultants Institutional's 13F filing for Q2 2026, filed 15 Jul 2026.